Nuvalent

IPO

Precisely targeted therapies for patients with cancer

About

Clinical-stage biopharmaceutical company creating precisely targeted therapies for patients with cancer using structure-based drug discovery.

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

BridgeBio Pharma is a clinical-stage biopharmaceutical company developing therapies for genetic d...

Clinical-stage biopharmaceutical company developing FcRn inhibitor therapies for IgG-mediated aut...

Commercial-stage oncology company pioneering antibody drug conjugate therapies for cancer treatment.

Biopharmaceutical oncology company focused on discovery, development, and commercialization of ca...

Global clinical-stage biopharmaceutical company pursuing novel drug development platforms for rar...

Research-based development stage biopharmaceutical company that discovers and develops innovative...